106 related articles for article (PubMed ID: 30927661)
1. FimH as a mucosal adjuvant enhances persistent antibody response and protective efficacy of the anti-caries vaccine.
Liu ZF; Chen JL; Li WY; Fan MW; Li YH
Arch Oral Biol; 2019 May; 101():122-129. PubMed ID: 30927661
[TBL] [Abstract][Full Text] [Related]
2. Flagellin enhances saliva IgA response and protection of anti-caries DNA vaccine.
Shi W; Li YH; Liu F; Yang JY; Zhou DH; Chen YQ; Zhang Y; Yang Y; He BX; Han C; Fan MW; Yan HM
J Dent Res; 2012 Mar; 91(3):249-54. PubMed ID: 22027714
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis.
Fan X; Yue Y; Xiong S
Antiviral Res; 2017 Apr; 140():121-132. PubMed ID: 28137624
[TBL] [Abstract][Full Text] [Related]
4. Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine.
Sun Y; Shi W; Yang JY; Zhou DH; Chen YQ; Zhang Y; Yang Y; He BX; Zhong MH; Li YM; Cao Y; Xiao Y; Li W; Yu J; Li YH; Fan MW; Yan HM
J Dent Res; 2012 Oct; 91(10):941-7. PubMed ID: 22895510
[TBL] [Abstract][Full Text] [Related]
5. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
[TBL] [Abstract][Full Text] [Related]
6. CCL17 combined with CCL19 as a nasal adjuvant enhances the immunogenicity of an anti-caries DNA vaccine in rodents.
Yan YH; Yu F; Zeng C; Cao LH; Zhang Z; Xu QA
Acta Pharmacol Sin; 2016 Sep; 37(9):1229-36. PubMed ID: 27546005
[TBL] [Abstract][Full Text] [Related]
7. Identification of FimH derivatives as adjuvant vaccinated with PAc that enhance protection against Streptcoccus mutans colonization.
Liu Z; Chen J; Li W; Bi Y; Li Y; Fan M
Mol Cell Probes; 2019 Jun; 45():19-25. PubMed ID: 30940544
[TBL] [Abstract][Full Text] [Related]
8. The pH-responsive zeolitic imidazolate framework nanoparticle as a promising immune-enhancing adjuvant for anti-caries vaccine.
Yu YB; Liu Y; Li S; Yang XY; Guo Z
J Dent; 2023 Mar; 130():104413. PubMed ID: 36634754
[TBL] [Abstract][Full Text] [Related]
9. Intranasal co-delivery of IL-6 gene enhances the immunogenicity of anti-caries DNA vaccine.
Su LK; Yu F; Li ZF; Zeng C; Xu QA; Fan MW
Acta Pharmacol Sin; 2014 May; 35(5):592-8. PubMed ID: 24705100
[TBL] [Abstract][Full Text] [Related]
10. [Protective efficacy of a new fusion anti-caries DNA vaccine encoding antigens of both Streptococcus mutans and Streptococcus sobrinus].
Sun JH; Niu YM; Fan MW; Xu QA; Yang XC
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2286-91. PubMed ID: 20095345
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
Jiang H; Hu Y; Yang M; Liu H; Jiang G
Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
Saito M; Otake S; Ohmura M; Hirasawa M; Takada K; Mega J; Takahashi I; Kiyono H; McGhee JR; Takeda Y; Yamamoto M
J Infect Dis; 2001 Mar; 183(5):823-6. PubMed ID: 11181162
[TBL] [Abstract][Full Text] [Related]
14. Immunogenic characterization and protection against Streptococcus mutans infection induced by intranasal DNA prime-protein boost immunization.
Li YH; Huang S; Du M; Bian Z; Chen Z; Fan MW
Vaccine; 2010 Jul; 28(32):5370-6. PubMed ID: 20573581
[TBL] [Abstract][Full Text] [Related]
15. Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents.
Cao XX; Li YH; Ye QL; Hu X; Wang TF; Fan MW
Hum Vaccin Immunother; 2017 Oct; 13(10):2332-2340. PubMed ID: 28759297
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
[TBL] [Abstract][Full Text] [Related]
17. Salivary IgA enhancement strategy for development of a nasal-spray anti-caries mucosal vaccine.
Yan H
Sci China Life Sci; 2013 May; 56(5):406-13. PubMed ID: 23633072
[TBL] [Abstract][Full Text] [Related]
18. A Lipopolysaccharide from Pantoea Agglomerans Is a Promising Adjuvant for Sublingual Vaccines to Induce Systemic and Mucosal Immune Responses in Mice via TLR4 Pathway.
Fukasaka M; Asari D; Kiyotoh E; Okazaki A; Gomi Y; Tanimoto T; Takeuchi O; Akira S; Hori M
PLoS One; 2015; 10(5):e0126849. PubMed ID: 25978818
[TBL] [Abstract][Full Text] [Related]
19. Enhanced efficacy of CTLA-4 fusion anti-caries DNA vaccines in gnotobiotic hamsters.
Zhang F; Li YH; Fan MW; Jia R; Xu QA; Guo JH; Yu F; Tian QW
Acta Pharmacol Sin; 2007 Aug; 28(8):1236-42. PubMed ID: 17640488
[TBL] [Abstract][Full Text] [Related]
20. FimH can directly activate human and murine natural killer cells via TLR4.
Mian MF; Lauzon NM; Andrews DW; Lichty BD; Ashkar AA
Mol Ther; 2010 Jul; 18(7):1379-88. PubMed ID: 20442710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
